Download FREE Report Sample
Download Free sampleAlogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (>99%).?
Alogliptin Market contains market size and forecasts of Alogliptin in global, including the following market information:
Global Alogliptin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alogliptin Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Alogliptin companies in 2021 (%)
The global Alogliptin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
6.25 Mg Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alogliptin include Takeda, Perrigo, Hikma Pharmaceuticals, Furiex Pharma, Allergan and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alogliptin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alogliptin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Alogliptin Market Segment Percentages, by Type, 2021 (%)
6.25 Mg Tablet
25 Mg Tablet
12.5 Mg Tablet
15 Mg Tablet
Other
Global Alogliptin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Alogliptin Market Segment Percentages, by Application, 2021 (%)
Diabetes
Hypercholesterolemia
Obesity
Other
Global Alogliptin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Alogliptin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alogliptin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alogliptin revenues share in global market, 2021 (%)
Key companies Alogliptin sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Alogliptin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
Perrigo
Hikma Pharmaceuticals
Furiex Pharma
Allergan
Sanofi
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
